ELAN
Elanco Animal Health·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 3
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Gap Down
Significant Net Income Decline
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ELAN
Elanco Animal Health Incorporated
A global leader in animal health and innovating products and services to prevent and treat disease in farm animals and pets
450 ELANCO CIRCLE
INDIANAPOLIS
INDIANA 46221
--
Elanco Animal Health Incorporated was incorporated in Indiana on May 3, 2018. Founded in 1954 as part of Eli Lilly and Company, Elanco is a premier animal health company dedicated to innovating, developing, producing and selling products for veterinarians and animal food. Headquartered in Greenfield, Indiana, the company is the fourth largest animal health company in the world. The company also has one of the broadest portfolios of pet parasites in the companion animal field. Elanco Animal Health offers a diverse portfolio of more than 125 brands, making it a trusted partner for veterinarians and animal food producers in more than 90 countries.
Earnings Call
Q1/2025
Estimate EPS0.3
Actual EPS0.37
Estimate Revenue1.17B
Actual Revenue1.19B
Elanco's Q1 2025 Earnings Call: Contradictions on Zenrelia's Market Share, Innovation Growth, and Investment Strategy
May 07,2025 07:24
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.2
Actual EPS0.26
Estimate Revenue1.19B
Actual Revenue1.24B
Elanco's Q2 2025 Earnings Call: Unraveling Key Contradictions in FX Impact, Innovation Growth, and Margin Dynamics
Aug 07,2025 05:50
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS0.13
Actual EPS0.19
Estimate Revenue1.09B
Actual Revenue1.14B
Elanco's Q3 2025 Earnings Call: Contradictions on Macroeconomic Impact, Zenrelia's Market Traction, and Quattro's Growth Potential
Nov 05,2025 10:26
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
ELAN has released its 2025 Q3 earnings. EPS was reported at 0.19, versus the expected 0.13, beating expectations. The chart below visualizes how ELAN has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ELAN has released its 2025 Q3 earnings report, with revenue of 1.14B, reflecting a YoY change of 10.39%, and net profit of -34.00M, showing a YoY change of -109.34%. The Sankey diagram below clearly presents ELAN's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
